Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine.

Stringer JS, Sinkala M, Chapman V, Acosta EP, Aldrovandi GM, Mudenda V, Stout JP, Goldenberg RL, Kumwenda R, Vermund SH
AIDS. 2003 17 (11): 1659-65

PMID: 12853748 · PMCID: PMC2745973 · DOI:10.1097/00002030-200307250-00010

MeSH Terms (19)

Adolescent Adult Breast Feeding Drug Administration Schedule Female HIV Infections HIV Seropositivity Humans Infant, Newborn Infectious Disease Transmission, Vertical Labor, Obstetric Nevirapine Obstetric Labor Complications Pregnancy Pregnancy Complications, Infectious Prospective Studies Reverse Transcriptase Inhibitors Risk Factors Time Factors

Connections (1)

This publication is referenced by other Labnodes entities: